Latest

neuropharmacology

This shows a woman on a scale with people pointing at her.

·April 17, 2026·8 min read

Decoding the Shame Associated with Ozempic Weight Loss

Women using GLP-1 drugs for weight loss face higher levels of stigma than those using diet and exercise, with many critics viewing the medication as a "shortcut."

Featured Neurology Neuroscience Pain

·April 16, 2026·8 min read

The Brain Circuitry of Placebo Pain Relief

Researchers have pinpointed the brain's "placebo circuit." By training the brain to release its own endorphins in the vlPAG region, they achieved broad-spectrum pain relief without the need for addictive drugs.

This shows an older man's nose surrounded by a mist.

Featured Neurology Neuroscience

·April 14, 2026·10 min read

Nasal Spray Reverses Brain Aging and Inflammation

A new two-dose nasal spray reverses brain aging by delivering microRNAs directly to the brain. The therapy reduces "neuroinflammation" and restores memory within weeks.

Featured Neuroscience

·April 13, 2026·5 min read

Enriched Environments Could Blunt Opioid Addiction

New research shows that environmental enrichment reduces fentanyl intake and prevents stress-induced relapse by lowering stress hormones, offering a scalable strategy for addiction treatment.

Featured Neurology Neuroscience

·April 11, 2026·7 min read

Parkinson’s Meds Accidentally Trigger Bacteria to “Eat” Levodopa

How does gut bacteria affect Parkinson’s medication? COMT inhibitors trigger the growth of E. faecalis, which metabolizes levodopa before it can reach the brain.

Featured Neurology Neuroscience

·April 9, 2026·7 min read

Micronutrients Could Stop Brain Bleeding in Alzheimer’s Treatment

Researchers have found that combining Alzheimer’s medications with molecules derived from grapes and turmeric is more effective and safer than current treatments, potentially reducing risks of brain swelling.

Featured Genetics Neuroscience

·April 8, 2026·8 min read

Ozempic Weight Loss Success Varies by DNA

A new study of 28,000 people identifies genetic markers in the GLP1R and GIPR genes that explain why some patients lose more weight or experience more nausea on GLP-1 drugs.

Autism Featured Genetics Neuroscience

·April 8, 2026·9 min read

One Compound Repairs Neurons with Autism Mutations

Researchers used a library of 520 FDA-approved drugs and zebrafish "behavioral fingerprints" to identify precision medicine candidates for autism. Levocarnitine emerged as a top drug for reversing symptoms linked to specific risk genes.

Featured Neurology Neuroscience Pain

·April 1, 2026·9 min read

High-Potency Opioid Relieves Pain Without the Risks

Researchers have engineered a novel nitazene-based opioid, DFNZ, that provides potent pain relief without causing respiratory depression or addiction. The "superagonist" drug could revolutionize treatment for chronic pain and opioid use disorder.